Device Firms Eye Rx Markets; Medtronic Moves Toward “Organ Restoration”
Executive Summary
Medtronic's long-term strategy is likely to include a much more prominent role in biotechnology, Senior VP-Medicine & Technology Stephen Oesterle told the recent Wharton Health Care Business Conference in Philadelphia